-
"Sky-high" life-saving drugs are included in medical insurance, how far is it to solve the difficulty of treating rare diseases
Time of Update: 2022-05-01
How to enable this group to achieve medical treatment for diseases, medicines for medicines, and insurance for medicines, so that more "high-priced medicines" can become affordable life-saving medicines for patients, and the rare disease protection system still needs to be continuously improved .
-
Changchun High-tech, Anke Bio-Abandoned Growth Hormone Market Pattern or Changes
Time of Update: 2022-05-01
Previously, on February 22, Changchun High-tech released an investor relations activity exchange form that revealed that as of the registration deadline for Guangdong Alliance's centralized drug procurement, the recombinant human growth hormone aqueous solution of its subsidiary Jinsai Pharmaceuticals has not been declared .
-
"Compilation of Medical Device Standard Catalogue (2022 Edition)" released
Time of Update: 2022-05-01
As of February 18, 2022, a total of 1,851 current medical device standards have been formulated and revised by the State Food and Drug Administration according to their responsibilities, including 235 national standards (91 mandatory standards, 144 recommended standards) and 1,616 industry standards.
-
Medical device supervision realizes six new 2021 supervision work inventory
Time of Update: 2022-05-01
The regulatory department insists on reform and innovation, consolidates and expands the reform achievements of the review and approval system, establishes the registrant system, improves the clinical evaluation requirements, promotes the construction of professional and professional inspector teams, strengthens the quality risk supervision of the whole life cycle, and increases the penalties for illegal acts.
-
The "Physician Law" will be officially implemented, where will the doctors of secondary school go?
Time of Update: 2022-05-01
02 Specific analysis of specific problems, secondary school education is "strategic retreat", and grassroots doctors with technical secondary school education will ask, since "the specific method" It is formulated by the competent health department of the State Council in conjunction with the education, traditional Chinese medicine and other relevant departments of the State Council .
-
Osaikang has accumulated a lot to release the first class 1 new drug benchmarking 4 billion varieties!
Time of Update: 2022-05-01
Table 1: Category 1 new drugs declared by Osaikang since 2020 Source: Minet database, CDE official website ASK120067 tablet is a third-generation EGFR inhibitor targeting T790M for the treatment of non-small cell lung cancer, Osaikang in 2017 After obtaining the clinical approval in 2019, the company obtained the CDE license in 2019 based on the outstanding results of the Phase I/II clinical study.
-
Chain pharmacies are facing layoffs due to the improvement of their digital capabilities
Time of Update: 2022-05-01
Improve digital capabilities and adapt to future competition It is worth mentioning that, in addition to reducing labor costs, chain pharmacies can also increase their strength against Internet platforms and face industry competition with a better attitude .
-
Jiangxi Province further strengthens the production management of Chinese herbal medicine pieces of Fresh Bamboo Lek
Time of Update: 2022-05-01
In order to further improve and strengthen our province's Fresh Bamboo Lek Chinese Herbal Pieces, ensure clinical efficacy, prevent product quality risks, and enhance the brand value of Gan-produced Chinese Herbal Pieces, we are now in accordance with the "Pharmaceutical Administration Law of the People's Republic of China" and "Measures for the Supervision and Administration of Drug Production", etc.
-
A batch of consumables will be collected: venous blood collection needle, indwelling needle, heparin cap...
Time of Update: 2022-05-01
The "Notice" pointed out that according to the centralized procurement of some medical consumables in Guangdong Province, the relevant enterprises that have maintained the product information of the basic library of 9 types of medical consumables such as intravenous indwelling needles have been maintained in the basic library of Shenzhen Sunshine Platform.
-
50 major retail varieties are included in price monitoring!
Time of Update: 2022-05-01
In 2020, the total sales of acarbose tablets in Chinese public medical institutions and Chinese urban physical pharmacy terminals will exceed 5 billion yuan, and it is the best-selling oral hypoglycemic drug in China .
-
276 drug centralized procurement of 11 provinces in Guangdong officially opened 58 exclusive varieties
Time of Update: 2022-05-01
The "Notice" clarifies that the lowest price is collected as of December 1, 2021 (inclusive) in all provinces (including Guangdong, Shanxi, Jiangxi, Henan, Guangxi, Hainan, Guizhou, Qinghai, Ningxia, Xinjiang, Xinjiang Production and Construction Corps) The lowest price (referring to the provincial online price or the provincial winning price).
-
Nearly 30 dosage forms of Sunshine Procurement will be listed on the Internet!
Time of Update: 2022-05-01
On March 4th, the Jiangsu Provincial Public Resource Trading Center issued a notice on the announcement of products to be listed on the Internet for the purchase of drugs by Sunshine.
-
The market potential is fully demonstrated, and the development of my country's orthopedic surgery robot industry is entering the fast lane
Time of Update: 2022-04-29
Based on China's huge population base, the acceleration of social aging, the gradual sinking of high-quality medical resources, and the promotion of the national artificial joint procurement policy, the market demand for orthopedic surgical robots in China is expected to be released in large quantities, and the industry will usher in a Rapid development .
-
Why do the 30 billion representatives behind the 30 yuan "like" to ask for money from medical insurance
Time of Update: 2022-04-29
30 billion behind 30 yuan This year's government work report proposed that the per capita financial subsidy standard for resident medical insurance should be increased by another 30 yuan .
-
What signal did the establishment of the "National Pharmaceutical Affairs Commission" send?
Time of Update: 2022-04-29
The establishment of the National Pharmaceutical Council has six main responsibilities . This means that the adjustment of the list of key monitored drugs may be in the third stage of review . Ju
-
The most difficult collection in history: dental implants stuck in the "mouth"
Time of Update: 2022-04-29
In February 2022, the relevant person in charge of the National Medical Insurance Bureau said: "In the first half of this year, we will strive to launch a coalition reform of the local centralized procurement of dental implants .
-
TOP20 Gynecological Chinese patent medicine retailer released 10 exclusive products "Baping"
Time of Update: 2022-04-29
com, sales of Xiaoyao Pills in urban physical pharmacies in China have risen steadily in recent years, and are expected to increase by more than 10% year-on-year in 2021, ranking second in the TOP20 gynecological Chinese patent medicine products .
-
The State Food and Drug Administration issued a recall order: Roche, Beckmann, Siemens...
Time of Update: 2022-04-29
BioMerieux’s cytomegalovirus IgM antibody detection kit VIDAS CMV IgM voluntarily recalled On February 28, the website of the State Drug Administration released the bioMerieux France S.
voluntarily recalls the ultrasonic diagnostic system On January 28, the website of the National Medical Products Administration reported that Siemens Medical Systems Co.
-
Announcement of the selection results of orthopaedic trauma medical consumables in 17 provinces of Beijing, Tianjin and Hebei
Time of Update: 2022-04-29
It is worth noting that the 12-province alliance of orthopaedic trauma in Henan has clearly required that if the same product has a new low price in the national or other provincial-level procurement, after the selected price takes effect, the procurement has not yet been implemented.
-
Can Liv Zhenzi always be below 5 yuan to attract the attention of businesses?
Time of Update: 2022-04-29
According to the introduction of the privet seed dealers in Henan and Shandong, the supply of goods in the origin is sufficient, and the market price has been stable with some decline compared with the same period of last year, the overall demand is not strong, and there are not many purchasers .
